BioPharm is Back!
In collaboration with EBD Group, MassBio will be bringing one of the largest and most productive
partnering events in North America back to Boston this fall.
BioPharm America™— which drew more than 900 people to Boston in 2010— will be held Sept. 7-9 at the Westin Waterfront. The event provides attendees with the opportunity to meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships.
This year, the conference will kick off with a keynote by Shire CEO Angus Russell. Russell is leading one of the most successful and admired global specialty biopharmaceutical companies in the world. He will share his insights and experience at the event.
Organized by the EBD Group and hosted by MassBio for the second consecutive year, BioPharm America continues its growth as the unrivaled business exchange in North America for the global life science industry, specifically designed to help companies raise capital, form in- or outlicensing agreements and enter co-development deals.
“We are proud to host this unique, high powered business exchange that so effectively brings together the international biotech partnering and financial communities here in Boston in 2011,” said MassBio President & CEO Robert K. Coughlin. “With Massachusetts’ strength in innovation and early stage research, active venture capital and finance community and participation from all the major pharma companies, the stage is set for BioPharm America 2011 to be the premier conference on the East Coast.”
The three-day event will pull together participants from the international and Massachusetts-based life science community, including representatives from venture capital, institutional and private equity investor communities; top level industry executives in business development, corporate development and strategic alliances; biotech and pharmaceutical executives; health care leaders; academic leaders; and representatives from disease foundations and government organizations offering financing opportunities. The event also features a top-notch program that includes the Defined Health Therapeutic Insight track, a finance/investment track, a personalized medicine track and dozens of company presentations.
Working together, these powerful elements will create a unique platform through which companies can efficiently identify and meet with potential partners from across the life sciences industry, and gain the intelligence needed to make better deals.
Additionally, BioPharm America 2011 will feature partneringONE®, the industry’s most advanced webbased networking system. With partneringONE, attendees can connect with their conference
community at all times, manage their conference activities in personal agenda files and search and bookmark companies of interest for easy follow-up.
“Partnering is essential to continued innovation in the life science industry,” said Carola Schropp, President of EBD Group. “That is why we are bringing our leading partnering platform back to Boston, the premier hub of life science innovation. Partnering at BioPharm America will enable emerging biotech innovators and large pharmaceutical firms to accelerate their strategic plans.”